Digital Variance Angiography for Contrast Media Dose Reduction in Carotid Artery Stenting

March 8, 2023 updated by: Kinepict Health Ltd.

Investigation of Dose Management Capabilities of Digital Variance Angiography: Contrast Media Dose Reduction in Patients Undergoing Carotid Artery Stenting - a Prospective Randomized Clinical Trial

Digital Variance Angiography (DVA) is a new tool in medical imaging with a proven image quality reserve (1, 2).

Previous studies have demonstrated the quality reserve of DVA in angiographic studies (1, 2), which allowed us to reduce contrast media use by 50% in carotid artery angiographic studies without affecting the image quality (3).

CAS is an alternative treatment option for carotid artery revascularization in selected patient groups. Similar to most of the minimally invasive endovascular interventions, CAS also carries the risk of contrast-induced acute kidney injury, which is considered to be an independent predictor of 30-day major adverse events (4).

The aim of this study is to apply DVA in patients undergoing carotid artery stenting (CAS) and utilize this technique to reduce contrast dose during the interventions, without affecting the intraprocedural radiation dose and the clinical outcome of the procedures. Investigators believe that the reduction in contrast media use and the associated image quality with the technique of DVA imaging can be incorporated into the everyday clinical practice, and will play an important role in improving the rate of contrast-induced acute kidney injury.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Budapest, Hungary, 1122
        • Recruiting
        • Semmelweis University, Heart and Vascular Center
        • Contact:
          • Péter Sótonyi, Prof,MD,PhD
        • Contact:
          • Balázs Nemes, MD,PhD
        • Sub-Investigator:
          • Márton Berczeli, M.D.
        • Sub-Investigator:
          • Marcell Gyánó, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 y
  • Carotid stenosis defined as:

Stenosis ≥70% by computer tomography angiography (NASCET criteria); OR by duplex-ultrasound with ≥70% stenosis defined by a peak systolic velocity of at least 230 cm/s

  • Carotid stenosis is treatable with CAS

Exclusion Criteria:

  • History of stroke or TIA ipsilateral to the stenosis within 30 days of randomization
  • Acute myocardial infarction
  • Severe chronic kidney disease: GFR>30ml/min/m2
  • Severe heart failure: NYHA IV
  • Severe liver failure: Child-Pugh 3
  • Iodine contrast allergy
  • Coagulopathy
  • Hematological bleeding disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: Reduced contrast media dose group

Reduced contrast media protocol: extracranial carotid artery intervention (2-4 fps according to the institutional protocol).

Contrast administration with an automatic contrast injector: angiographic image acquisitions will be performed with 6 ml of 50% contrast media (3 ml iodined contrast media, 3 ml physiologic saline) with a 3 ml/s flow rate.

DSA and DVA images will be calculated; DVA images will be used for diagnosis and interventions.

Radial, brachial or femoral arterial access is gained by using the Seldinger technique. The common carotid artery (CCA) is catheterized. Selective angiography is performed from the anteroposterior and lateral view without magnification. Initial angiograms are performed with the reduced contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the common carotid artery. The carotid arterial lesion is crossed and an embolic protection device is deployed in the internal carotid artery. Carotid artery stenting is performed in a standard fashion. Post-stenting angiographies are obtained with the reduced contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the CCA. Pre- and post-stenting angiographies are performed with the same sheath position. DSA and DVA images will be calculated on a commercially available image processing workstation and the Kinepict Medical Imaging Tool.
Other Names:
  • Carotid artery stenting
  • Arterial access
  • Preinterventional selective carotid artery angiography
  • Postinterventional selective carotid artery angiography
Pre- and postinterventional assessment of the treated internal carotid artery.
Active Comparator: Group B: Standard contrast media dose group

Standard contrast media protocol: extracranial carotid artery intervention (2-4 fps according to the institutional protocol).

Contrast administration with an automatic contrast injector: angiographic image acquisitions will be performed with 6 ml iodined contrast media with a 3 ml/s flow rate.

DSA and DVA images will be calculated; DSA images will be used for diagnosis and interventions.

Pre- and postinterventional assessment of the treated internal carotid artery.
Radial, brachial or femoral arterial access is gained by using the Seldinger technique. The common carotid artery (CCA) is catheterized. Selective angiography is performed from the anteroposterior and lateral view without magnification. Initial angiograms are performed with standard contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the common carotid artery. The carotid arterial lesion is crossed and an embolic protection device is deployed in the internal carotid artery. Carotid artery stenting is performed in a standard fashion. Post-stenting angiographies are obtained with the standard contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the CCA. Pre- and post-stenting angiographies are performed with the same sheath position. DSA and DVA images will be calculated on a commercially available image processing workstation and the Kinepict Medical Imaging Tool.
Other Names:
  • Carotid artery stenting
  • Arterial access
  • Preinterventional selective carotid artery angiography
  • Postinterventional selective carotid artery angiography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DSA-related contrast media use
Time Frame: During the procedure
Volume of the iodinated contrast agent used for enhancing the image quality (mL)
During the procedure
Total procedural contrast media use
Time Frame: During the procedure
Volume of the iodinated contrast agent used for enhancing the image quality (mL)
During the procedure
Image quality, graded by independent observers
Time Frame: through study completion, an average of 1 year
Observations based on a 5-level Likert scale (1-poor image quality, 3-medium image quality, 5-outstanding image quality)
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total procedural dose area product
Time Frame: During the procedure
Indicator of a patient's irradiation dosage (microGy*cm2 or Gy*cm2)
During the procedure
DSA-related dose area product
Time Frame: During the procedure
Indicator of a patient's irradiation dosage (microGy*cm2 or Gy*cm2)
During the procedure
Total procedural time
Time Frame: During the procedure
Duration of the whole procedure, from arterial access till the removal of every tool (min)
During the procedure
Number of protocol changes during DVA usage
Time Frame: During the procedure
Number of occasions when the reduced contrast media protocol has to be switched back to conventional protocol because of the unsuitable image quality
During the procedure
Residual stenosis
Time Frame: During the procedure
The difference between the normal reference segment diameter and the minimum lumen diameter of the treated lesion after CAS (%)
During the procedure
Focal neurological symptoms
Time Frame: During the procedure and up to 1 day
Focal neurological symptoms ipsilateral to the treated carotid artery during the postprocedural observation period
During the procedure and up to 1 day
Preoperative and postoperative ipsilateral carotid artery flow by doppler ultrasound
Time Frame: Preoperatively and 1 day after the procedure
Peak-systolic and end-diastolic velocities (cm/sec)
Preoperatively and 1 day after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Anticipated)

October 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

February 23, 2021

First Submitted That Met QC Criteria

March 9, 2021

First Posted (Actual)

March 10, 2021

Study Record Updates

Last Update Posted (Estimate)

March 9, 2023

Last Update Submitted That Met QC Criteria

March 8, 2023

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Artery Diseases

Clinical Trials on Carotid artery stenting with reduced contrast media protocol

Subscribe